Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status.

Carola DeischingerMagdalena BastianKaroline LeitnerDagmar Bancher-TodescaHerbert KissSabina Baumgartner-ParzerAlexandra Kautzky-WillerJuergen Harreiter

Published in: Acta diabetologica (2023)

Gremlin-1 levels decreased significantly during pregnancy. The biomarker is not related to GDM status, but correlates negatively with the Insulinogenic Index, an index related to beta cell function. Trial Registry Number ACTRN12616000924459.

Keyphrases

healthcare
public health
clinical trial
pregnant women
mental health
study protocol
randomized controlled trial
bone mineral density
health information
phase ii
risk assessment
climate change
social media
human health
open label